Home / Import refusals / NQV-0001013-5/10002/1B

FDA Import Refusal NQV-0001013-5/10002/1B — The Procter & Gamble Manufacturing Company

The Procter & Gamble Manufacturing Company — FEI 1033800

The FDA refused shipment NQV-0001013-5/10002/1B from The Procter & Gamble Manufacturing Company (United States) on May 19, 2026. The refused product falls under Drugs and Biologics — ASTRINGENT/ANTI-PERSPIRANT N.E.C.. Cited charges: 118,2280,3280,335 This firm has 5 or more other import refusals on record.

Refusal Details

Date
May 19, 2026
Country
United States
Product Category
Drugs and Biologics
Product Code
62WAY99 ASTRINGENT/ANTI-PERSPIRANT N.E.C.
Charges
118,2280,3280,335

Recent inspections

  • 1162837 (VAI Fri Feb 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1007310 (VAI Fri Mar 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 740165 (NAI Thu Aug 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 609285 (NAI Thu Aug 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • SCS-5302648-5/20001/1 (Mon Dec 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 98F-0106299-9/21/1 (Fri Feb 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 9DH-0052971-4/31/1 (Wed Jul 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 231-4534003-6/11/1 (Fri Jul 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-8903346-1/171/2 (Wed Jul 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Devices)

FDA data resources